课题基金 / 基金详情

Hyperpolarized 129Xe Imaging of Pulmonary Gas Exchange

Hyperpolarized 129Xe Imaging of Pulmonary Gas Exchange
肺部气体交换的超极化 129Xe 成像
批准号:
7456608
负责人:
Bastiaan Driehuys
金额:
$22.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2010-06-30

项目摘要

项目成果

Bastiaan Driehuys的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们的全球目标是开发一种使用超极化129 MRI的稳健的肺部气体交换成像方法,该方法可用于临床和涉及气体交换异常的肺部疾病的小动物研究。我们建议显着提高分辨率和准确性,我们最近展示的129氚气体交换成像方法,测试其检测限,比较该方法与其最可能的竞争-高分辨率CT,并比较它的金标准-组织学。一种非侵入性和有效的生物标志物可能会导致我们诊断,治疗和理解间质性肺病的能力发生巨大变化。这项研究将在大鼠中进行,并为预期的临床转化奠定基础。我们的方法使用超极化的129氚来差分成像129氚摄取到肺血/气屏障和红细胞中。与热极化相比,超极化使129 μ m MRI信号增加了5个数量级,使高分辨率气体成像成为可能。大的129化学位移使我们能够区分空气空间,血液/气体屏障和红细胞隔室中的129。为了使129到达红细胞,它必须首先穿过血液/气体屏障。由于扩散运输时间与屏障厚度的平方成比例,因此红细胞中129氚摄取的成像非常灵敏,能够检测屏障厚度的5 μ m变化。到目前为止,气体交换过程的直接成像还不可能通过任何方法实现。除了通气和灌注,气体交换是肺功能最基本的方面。肺气体交换受损发生在许多病理中,但在早期阶段很难明确评估,而此时干预最有可能有效。诸如肺纤维化、炎症和放射性肺炎等疾病最初可能不会显著改变通气或灌注。只有当疾病发展到非常晚期时,才能通过高分辨率CT上的密度增加来诊断显著的结构异常。拟议的工作将增加一个基本的和敏感的新能力,肺部疾病成像。完成拟议的工作将确保该方法将准备好转化为临床环境,并在肺部疾病的纵向评价动物模型的常规应用。这项工作将开发一种新的和非侵入性的方法来成像肺气体交换异常。它对于间质性肺疾病如肺纤维化的早期诊断特别相关。项目完成后,该方法应准备好用于临床环境。
英文摘要
DESCRIPTION (provided by applicant): Our global aim is to develop a robust pulmonary gas exchange imaging method using hyperpolarized 129Xe MRI, which can be used clinically and in small animal research of pulmonary diseases involving gas exchange abnormalities. We propose to significantly improve the resolution and accuracy of our recently demonstrated 129Xe gas exchange imaging method, test its detection limits, compare the method to its most likely competition - high-resolution CT, and compare it to the gold standard - histology. A noninvasive and effective biomarker could lead to a dramatic change in our ability to diagnose, treat, and understand interstitial lung diseases. This research will be carried out in rats and lays the groundwork for anticipated clinical translation. Our method uses hyperpolarized 129Xe to differentially image 129Xe uptake into pulmonary blood/gas barrier and red blood cells. Hyperpolarization increases the 129Xe MRI signal by 5 orders of magnitude compared to thermal polarization, making high resolution gas imaging possible. The large 129Xe chemical shift enables us to discriminate 129Xe in airspace, blood/gas barrier, and red blood cell compartments. For 129Xe to reach the red blood cells, it must first traverse the blood/gas barrier. Since diffusive transport times scale as the square of barrier thickness, imaging of 129Xe uptake in red blood cells is exquisitely sensitive and capable of detecting 5¿m changes in barrier thickness. Until now, direct imaging of the gas exchange process has not been possible by any method. In addition to ventilation and perfusion, gas exchange is the most fundamental aspect of lung function. Impairment of pulmonary gas exchange occurs in numerous pathologies, but is difficult to assess definitively at early stages when intervention is most likely to be effective. Diseases such as pulmonary fibrosis, inflammation, and radiation induced pneumonitis initially may not dramatically change ventilation or perfusion. Only once the disease is very advanced, can significant structural abnormalities be diagnosed via density increases noted on high-resolution CT. The proposed work will add a fundamental and sensitive new capability to pulmonary disease imaging. Completion of the proposed work will ensure that this method will be ready for translation to a clinical setting, and to the routine application in longitudinal evaluation animal models of pulmonary disease. The proposed work will develop a novel and non-invasive method for imaging pulmonary gas exchange abnormalities. It is particularly relevant for the early diagnosis of interstitial lung diseases such as pulmonary fibrosis. Upon completion of the project, the method should be ready for translation to a clinical setting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Xenon MRI in Pulmonary Hypertension
  • 批准号:
    10670092
  • 项目类别:
  • 资助金额:
    $76.36万
  • 财政年份:
    2021
  • 负责人:
    Bastiaan Driehuys
  • 依托单位:
Xenon MRI in Pulmonary Hypertension
  • 批准号:
    10415160
  • 项目类别:
  • 资助金额:
    $76.95万
  • 财政年份:
    2021
  • 负责人:
    Bastiaan Driehuys
  • 依托单位:
Xenon MRI in Pulmonary Hypertension
  • 批准号:
    10204681
  • 项目类别:
  • 资助金额:
    $66.6万
  • 财政年份:
    2021
  • 负责人:
    Bastiaan Driehuys
  • 依托单位:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
  • 批准号:
    9064201
  • 项目类别:
  • 资助金额:
    $74.71万
  • 财政年份:
    2015
  • 负责人:
    Bastiaan Driehuys
  • 依托单位:
海外基金